Early B cell transcriptomic markers of measles-specific humoral immunity following a 3rd dose of MMR vaccine is a research paper published in Frontiers in Immunology (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: R01 AI033144
NIAID NIH HHS
Grant: R01 AI121054
NIAID NIH HHS
Grant: R01 AI138965
NIAID NIH HHS
Grant: R01 AI12736
NIAID NIH HHS
Grant: R01 AI127365
National Institutes of Health
Grant: 5R01AI138965-05
Systems Biology of Mumps Vaccine Response
National Institutes of Health
Grant: 1R01AI127365-01
Genetic Markers of Long-Term Mumps Vaccine Immunity
National Institutes of Health
Grant: 5R01AI033144-03
MEASLES IMMUNITY IN TWO POPULATIONS
National Institutes of Health
Grant: 5R01AI121054-03
Understanding measles vaccine failure (and success) in Southern India
FWCI
0.61
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals